Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Dexmedetomidine Sedation on Memory Consolidation
NCT05045170Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- May 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of propofol and dexmedetomidine in Procedural sedation (PS) (3 arms), sponsored by Sechenov First Moscow State Medical University. Primary endpoint: Memory consolidation impairment with sedation at 24 hours. Started May 2021; status: completed.
02
Drugs
propofoldexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05045170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045170.